CXCR2 antagonist 8
CXCR2 antagonist 8 is a potent and selective CXCR2 antagonist. CXCR2 antagonist 8 can be used for insulin resistance research[1].
Product Specifications
CAS Number
[182498-30-2]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/cxcr2-antagonist-8.html
Concentration
10mM
Purity
98.38
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC=C1OC)NC2=CC=C([N+]([O-])=O)C=C2O
Molecular Formula
C14H13N3O5
Molecular Weight
303.27
Precautions
H302, H315, H319, H335
References & Citations
[1]Lluis Fajas, et al. Cxcr2 receptor antagonists for the treatment or the prevention of insulin resistance. WO2010092440A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
BCAS1, NT (BCAS1, AIBC1, NABC1, Breast carcinoma-amplified sequence 1, Amplified and overexpressed in breast cancer, Novel amplified in breast cancer 1)
BCAS1, NT (BCAS1, AIBC1, NABC1, Breast carcinoma-amplified sequence 1, Amplified and overexpressed in breast cancer, Novel amplified in breast cancer 1)
